Context sidebar

New on this website

25.06.2026

DHPC – Miostat (carbacholum)

Abweichung in den Packungsmaterialien (Faltschachtel, Blister; Etikette, Packungsbeilage)

25.06.2026

Chargenrückruf – Mycostatin, Suspension zum Einnehmen 100'000 I.E./ml

Rückzug der Charge 55234 bis auf Stufe Patient

23.06.2026

Out-of-Stock – Betaseptic, alkoholische Povidon-Iod-Lösung 1000 ml

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung

23.06.2026

Summary report on authorisation - Enhertu®

Extension of therapeutic indication (06)

22.06.2026

DHPC – MisoOne (misoprostolum)

Wichtige Sicherheitsinformation

22.06.2026

Summary report on authorisation – mRESVIA®

Extension of therapeutic indication (01)

22.06.2026

Summary report on authorisation – Breyanzi®

Extension of therapeutic indication (02)

22.06.2026

Summary report on authorisation – Winrevair®

Indication extension (01)

22.06.2026

Meeting of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)

The Assembly of the ICH met in person on 2–3 June 2026 in Rio de Janeiro, Brazil, for its biannual meeting

19.06.2026

New options for registering devices in swissdamed: Online editor, Machine-to-Machine (M2M) interface, and Master UDI-DI registration

Thanks to a user-friendly online editor and a M2M interface, the registration process in the UDI Devices module is simpler, faster, and better adapted to different user needs. The registration of contact lenses that require a Master UDI-DI is now also supported.

19.06.2026

Revision of the Swissmedic Fees Ordinance on 1 July 2026

New fee schedule for charging by time

19.06.2026

Chargenrückruf – Fixaprost, Augentropfen Einzeldosen

Rückzug der Charge 3X74 bis auf Stufe Patient

18.06.2026

Updated information sheet about the requirements for the maintenance of sterilization containers

The information sheet on the requirements for the maintenance of sterilization containers has been updated and further detailed

18.06.2026

Revised annex 3a TPLRO

Polysorbates as excipients of particular interest

15.06.2026

Senior Controller/in (80 - 100%)

Stellenausschreibung | Finanzen und Controlling

15.06.2026

DHPC – Menopur Multidose (menotropinum)

Wichtige Mitteilung zur Arzneimittelsicherheit

15.06.2026

SEND datasets for new authorisation applications for human medicinal products with new active substances

Submission will be mandatory from 15 June 2026

12.06.2026

Swissmedic publishes its Annual Report and financial statements for 2025

Federal Council approves Swissmedic’s Annual Report and financial statements

09.06.2026

DHPC – Tigecyclin Leman (tigecyclinum)

Abweichung zwischen dem im 2D-Barcode auf der Umverpackung kodierten Verfallsdatum und dem lesbaren Verfallsdatum

08.06.2026

DHPC – Vyvgart® (efgartigimod alfa)

Wichtige Mitteilung zur Arzneimittelsicherheit

08.06.2026

DHPC – Dafalgan® (paracetamolum)

Packungsbeilage mit fehlendem Sicherheitshinweis

08.06.2026

DHPC – Dafalgan® DOLO (paracetamolum)

Packungsbeilage mit fehlendem Sicherheitshinweis

08.06.2026

Out-of-Stock – YERVOY 200mg/40ml Konzentrat zur Herstellung einer Infusionslösung

Befristete Bewilligung zum Vertrieb in italienischer Aufmachung

08.06.2026

Studies by Swissmedic, University Hospital Zurich and the University of Zurich have analysed the assessment of cancer drugs

Successful collaboration in the analysis of authorisation data for oncology drugs over the last 20 years in Switzerland

04.06.2026

Summary report on authorisation – Yselty®

First authorisation

04.06.2026

Swissmedic Journal

Latest edition
Swissmedic Journal May 2026

01.06.2026

Updated guidelines for quality assurance in transfusion practice

The second version of the guidelines has been updated and expanded

01.06.2026

swissdamed Webinar: How to register and manage medical device data in swissdamed

Presentation and recording now available

01.06.2026

Summary report on authorisation – BCG-medac®

First authorisation

01.06.2026

Summary report on authorisation – Rybelsus®

Extension of therapeutic indication (01)

01.06.2026

Summary report on authorisation – Alhemo®

Extension of therapeutic indication (01)

01.06.2026

Changes to the Project Orbis guidance document

Project Orbis guidance document updated

01.06.2026

Safety Update – product information updates

Product information: new safety-related updates (June 2026)

29.05.2026

Out-of-Stock – Opdivo 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung

29.05.2026

Summary report on authorisation – RoTecPSMA®

First authorisation

28.05.2026

DHPC – Evrysdi® (Risdiplamum)

Important drug safety notification

28.05.2026

Federal contribution to the Swiss Agency for Therapeutic Products Swissmedic to be increased

Federal Council press release

19.05.2026

Batch recall – Oculac Augentropfen, Oculac SDU

Rückruf aller Chargen bis auf Stufe Detailhandel

13.05.2026

Direktionsassistent/in (80–100%)

Stellenausschreibung | Direktionssekretariat

11.05.2026

Clinical trials of medicinal products and ATMPs with multiple sponsors

Compliant implementation
Permanent link of this page
www.swissmedic.ch/updates-en
News channel of this page
Newsletter
New on the website

Last modification 01.02.2026

Top of page